Michaeli, D., Yagmur, H. B., Achmadeev, T., & Michaeli, C. T. (2022). Valuation and returns of drug development companies: Lessons for bioentrepreneurs and investors. Therapeutic innovation & regulatory science, 56(2), . https://doi.org/10.1007/s43441-021-00364-y
Chicago Style (17th ed.) CitationMichaeli, Daniel, Hasan Basri Yagmur, Timur Achmadeev, and Christoph T. Michaeli. "Valuation and Returns of Drug Development Companies: Lessons for Bioentrepreneurs and Investors." Therapeutic Innovation & Regulatory Science 56, no. 2 (2022). https://doi.org/10.1007/s43441-021-00364-y.
MLA (9th ed.) CitationMichaeli, Daniel, et al. "Valuation and Returns of Drug Development Companies: Lessons for Bioentrepreneurs and Investors." Therapeutic Innovation & Regulatory Science, vol. 56, no. 2, 2022, https://doi.org/10.1007/s43441-021-00364-y.